Measles burden in urban settings: characteristics of measles cases in Addis Ababa city administration, Ethiopia, 2004-2014. 2017

Amare Mengistu Mersha, and Fiona Braka, and Kathleen Gallagher, and Aysheshim Ademe Tegegne, and Aron Kassahun Argay, and Mekonnen Admassu Mekonnen, and Merawi Aragaw, and Debritu Mengesha Abegaz, and Etsehiwot Zeamlak Worku, and Mekonen Getahun Baynesagn
World Health Organization, Ethiopia.

BACKGROUND In developing countries, measles was a major cause of morbidity and mortality before the wide spread use of measles vaccine. The purpose of this study was to describe measles burden in an urban setting, Addis Ababa- since the implementation of measles case-based surveillance in Ethiopia. We analyzed measles surveillance data for 2004 -2014. METHODS Incidence of measles was described by sub city, by year and by age groups. Age specific incidence rate were calculated. Logistic regression was used to identify the predictors of confirmed measles cases. RESULTS Of 4220 suspected measles cases 39% were confirmed cases. Males and females were equally affected. The mean affected age was 7.59 years. Measles cases peaked in 2010 and 2013-2014. Incidence of measles is higher among children less than five years old. Outer sub cities were more affected by measles in all years. CONCLUSIONS Sub cities bordering with Oromia Regional State were more affected by measles. Older age groups were more affected than younger age groups (age ≤ five years old). Efforts to close immunity gaps against measles and further strengthen surveillance in urban settings, particularly among children below five years old, should be prioritized.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008457 Measles A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM. Rubeola
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles
D011159 Population Surveillance Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy. Surveillance, Population
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003906 Developing Countries Countries in the process of change with economic growth, that is, an increase in production, per capita consumption, and income. The process of economic growth involves better utilization of natural and human resources, which results in a change in the social, political, and economic structures. LMICs,Less-Developed Countries,Low Income Countries,Low and Middle Income Countries,Lower-Middle-Income Country,Middle Income Countries,Third-World Countries,Under-Developed Countries,Developing Nations,Least Developed Countries,Less-Developed Nations,Third-World Nations,Under-Developed Nations,Countries, Middle Income,Countries, Third-World,Country, Least Developed,Country, Less-Developed,Country, Low Income,Country, Lower-Middle-Income,Country, Middle Income,Country, Third-World,Country, Under-Developed,Developed Country, Least,Developing Country,Developing Nation,Least Developed Country,Less Developed Countries,Less Developed Nations,Less-Developed Country,Less-Developed Nation,Low Income Country,Lower Middle Income Country,Lower-Middle-Income Countries,Middle Income Country,Nation, Less-Developed,Nation, Third-World,Nation, Under-Developed,Third World Countries,Third World Nations,Third-World Country,Third-World Nation,Under Developed Countries,Under Developed Nations,Under-Developed Country,Under-Developed Nation
D005002 Ethiopia An independent state in eastern Africa. Ethiopia is located in the Horn of Africa and is bordered on the north and northeast by Eritrea, on the east by Djibouti and Somalia, on the south by Kenya, and on the west and southwest by Sudan. Its capital is Addis Ababa. Federal Democratic Republic of Ethiopia
D005260 Female Females

Related Publications

Amare Mengistu Mersha, and Fiona Braka, and Kathleen Gallagher, and Aysheshim Ademe Tegegne, and Aron Kassahun Argay, and Mekonnen Admassu Mekonnen, and Merawi Aragaw, and Debritu Mengesha Abegaz, and Etsehiwot Zeamlak Worku, and Mekonen Getahun Baynesagn
September 2023, African journal of emergency medicine : Revue africaine de la medecine d'urgence,
Amare Mengistu Mersha, and Fiona Braka, and Kathleen Gallagher, and Aysheshim Ademe Tegegne, and Aron Kassahun Argay, and Mekonnen Admassu Mekonnen, and Merawi Aragaw, and Debritu Mengesha Abegaz, and Etsehiwot Zeamlak Worku, and Mekonen Getahun Baynesagn
April 1972, Ethiopian medical journal,
Amare Mengistu Mersha, and Fiona Braka, and Kathleen Gallagher, and Aysheshim Ademe Tegegne, and Aron Kassahun Argay, and Mekonnen Admassu Mekonnen, and Merawi Aragaw, and Debritu Mengesha Abegaz, and Etsehiwot Zeamlak Worku, and Mekonen Getahun Baynesagn
January 2018, BioMed research international,
Amare Mengistu Mersha, and Fiona Braka, and Kathleen Gallagher, and Aysheshim Ademe Tegegne, and Aron Kassahun Argay, and Mekonnen Admassu Mekonnen, and Merawi Aragaw, and Debritu Mengesha Abegaz, and Etsehiwot Zeamlak Worku, and Mekonen Getahun Baynesagn
August 2018, BMC infectious diseases,
Amare Mengistu Mersha, and Fiona Braka, and Kathleen Gallagher, and Aysheshim Ademe Tegegne, and Aron Kassahun Argay, and Mekonnen Admassu Mekonnen, and Merawi Aragaw, and Debritu Mengesha Abegaz, and Etsehiwot Zeamlak Worku, and Mekonen Getahun Baynesagn
June 2003, Epidemiology and infection,
Amare Mengistu Mersha, and Fiona Braka, and Kathleen Gallagher, and Aysheshim Ademe Tegegne, and Aron Kassahun Argay, and Mekonnen Admassu Mekonnen, and Merawi Aragaw, and Debritu Mengesha Abegaz, and Etsehiwot Zeamlak Worku, and Mekonen Getahun Baynesagn
December 1990, East African medical journal,
Amare Mengistu Mersha, and Fiona Braka, and Kathleen Gallagher, and Aysheshim Ademe Tegegne, and Aron Kassahun Argay, and Mekonnen Admassu Mekonnen, and Merawi Aragaw, and Debritu Mengesha Abegaz, and Etsehiwot Zeamlak Worku, and Mekonen Getahun Baynesagn
January 1993, Tropical and geographical medicine,
Amare Mengistu Mersha, and Fiona Braka, and Kathleen Gallagher, and Aysheshim Ademe Tegegne, and Aron Kassahun Argay, and Mekonnen Admassu Mekonnen, and Merawi Aragaw, and Debritu Mengesha Abegaz, and Etsehiwot Zeamlak Worku, and Mekonen Getahun Baynesagn
August 2022, Heliyon,
Amare Mengistu Mersha, and Fiona Braka, and Kathleen Gallagher, and Aysheshim Ademe Tegegne, and Aron Kassahun Argay, and Mekonnen Admassu Mekonnen, and Merawi Aragaw, and Debritu Mengesha Abegaz, and Etsehiwot Zeamlak Worku, and Mekonen Getahun Baynesagn
May 2023, Heliyon,
Amare Mengistu Mersha, and Fiona Braka, and Kathleen Gallagher, and Aysheshim Ademe Tegegne, and Aron Kassahun Argay, and Mekonnen Admassu Mekonnen, and Merawi Aragaw, and Debritu Mengesha Abegaz, and Etsehiwot Zeamlak Worku, and Mekonen Getahun Baynesagn
March 2020, Environmental health and preventive medicine,
Copied contents to your clipboard!